Name: Tesamorelin

Alias: TH9507 CAS Registry number: 218949-48-5 Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH? Molecular Formula: C???H???N??O??S Molecular Weight: 3622.3 Da Purity: ≥99% (by HPLC) Appearance: White lyophilized powder Packing: 10 vials/box (10mg total per vial) Product Group: Growth hormone releasing hormone analog peptide

Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.

Brief Introduction:

Tesamorelin is a synthetic GHRH analog with structural amino acid substitution, exclusively for laboratory research. It exhibits enhanced metabolic stability and stronger GHRH receptor affinity compared with natural growth hormone-releasing hormone. It effectively stimulates pituitary gland to secrete endogenous growth hormone in a physiological pulsatile pattern, improves IGF-1 concentration, and specifically reduces visceral adipose tissue accumulation. It plays key roles in regulating lipid metabolism, endocrine balance and body composition, widely used in metabolic endocrinology, fat redistribution and physiological aging research.

Main Research Applications:

Growth hormone endocrine regulation research: Used in cell and animal models to study enhanced GHRH receptor activation and physiological pulsatile GH secretion. Visceral fat metabolism research: Suitable for exploring visceral lipolysis, fat redistribution and abnormal lipid metabolism improvement pathways. Endocrine & metabolic balance research: Applied to investigate IGF-1 modulation and long-term metabolic homeostasis maintenance. Body composition optimization research: For comparative analysis of adipose reduction and lean tissue retention effects.

Metabolic aging intervention research: Study the improvement of age-related endocrine decline and metabolic disorders.